← Back to Search

Sequenced Reverse Recall of Digits--Auditory for Delay Discounting (RehabEF Trial)

N/A

Recruiting

Led By Richard Yi, PhD

Research Sponsored by University of Kansas

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline; week 6-8; month 3; month 6

Awards & highlights

RehabEF Trial Summary

This trial will attempt to reduce unhealthy behaviors in mid-life individuals by training them in executive function skills.

Who is the study for?

This trial is for mid-life individuals in Baltimore neighborhoods willing to join a 5-7 week cognitive training program. It's not for those with severe substance use (except tobacco), major depression, or conditions like traumatic brain injury, dementia, significant learning disabilities, or schizophrenia.Check my eligibility

What is being tested?

The study tests if special memory and verbal exercises can help people make better health decisions by improving their ability to wait for rewards. Participants will do tasks involving recalling words and numbers both visually and audibly.See study design

What are the potential side effects?

Since the interventions are non-medical cognitive training exercises, traditional physical side effects are not expected. However, participants may experience mental fatigue or stress.

RehabEF Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline; week 6-8; month 3; month 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline; week 6-8; month 3; month 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; week 6-8; month 3; month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Delay Discounting (DD)

Secondary outcome measures

Change in Hopkins Verbal Learning Test

Change in Iowa Gambling Task

Change in Letter Numbering Sequencing (LTC)

+1 more

Other outcome measures

Change in Chernyshenko Conscientiousness Scale (CCS)

Change in Patient Activation Measure

Change in The Multidimensional Health Locus of Control

+8 more

RehabEF Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Active Training (AT) GroupExperimental Treatment4 Interventions

Participants will complete four computerized training programs to improve executive function (EF), including Sequenced Recall of Digits - Auditory, Sequenced Reverse Recall of Digits - Auditory, Sequenced Recall of Words - Visual, Verbal Memory - Visual.

Group II: Control Training (CT) GroupActive Control1 Intervention

Participants will complete the four computerized programs relating to executive function (EF), but will be provided with the answer (i.e., without memory requirements). That is, participants in the control condition will not be asked to engage their cognitive functions.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Maryland, BaltimoreOTHER

688 Previous Clinical Trials

373,976 Total Patients Enrolled

Michigan State UniversityOTHER

185 Previous Clinical Trials

601,298 Total Patients Enrolled

University of FloridaOTHER

1,340 Previous Clinical Trials

715,025 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what demographic is this research opportunity accessible?

"If individuals hope to take part in this research, they must possess a propensity for delay discounting and be within the age range of 40-60. Currently, there are about 432 participants enrolled in the trial."

Answered by AI

Is there currently any recruitment taking place for this medical experiment?

"This experiment, which was initially posted on November 1st 2014 and last adjusted on May 16th 2022, is not actively recruiting participants at this time. However, there are alternative clinical trials that offer enrolment opportunities for prospective patients."

Answered by AI